Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
about
Validation of a self-administered computerized system to detect cognitive impairment in older adultsImproving drug trials for mild to moderate Alzheimer's disease.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study.Economic evaluation of the impact of memantine on time to nursing home admission in the treatment of Alzheimer disease.
P2860
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@ast
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@en
type
label
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@ast
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@en
prefLabel
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@ast
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@en
P2860
P1433
P1476
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.
@en
P2093
Linus Jönsson
P2860
P304
P356
10.2165/00019053-200321140-00003
P577
2003-01-01T00:00:00Z
P6179
1036999918